Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.

In 2024, we continue to execute on our plans, shifting our efforts toward internal programs and to completing our CMC and GMP investments ... Stephen Willey with Stifel. You may proceed.

ST. LOUIS, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for January 31, 2025 in an effort to provide timely information to investors on ...

Looking at the universe of stocks we cover at Dividend Channel, on 3/3/25, Newmark Group Inc (Symbol: NMRK), Cohen & Steers Inc (Symbol: CNS), and Stifel Financial Corporation (Symbol: SF ...

ST. LOUIS, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for January 31, 2025 in an effort to provide timely information to ...